HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $478,188 | +44.0% | 8,404 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $332,000 | -10.3% | 8,404 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $370,000 | +10.4% | 8,404 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $335,000 | -15.8% | 8,404 | -15.2% | 0.00% | 0.0% |
Q4 2021 | $398,000 | -1.2% | 9,907 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $403,000 | -10.4% | 9,907 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $450,000 | +9.0% | 9,907 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $413,000 | -10.0% | 9,907 | -7.9% | 0.00% | -33.3% |
Q4 2020 | $459,000 | +62.2% | 10,754 | +0.0% | 0.00% | +50.0% |
Q3 2020 | $283,000 | -1.7% | 10,752 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $288,000 | – | 10,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |